ライフサイエンスコーパス: vesicular acetylcholine transporter

1 d by the immunostaining of fibers for VAChT (vesicular acetylcholine transporter).

2 we used brain sections immunostained for the vesicular acetylcholine transporter.

3 binding of (123)I-iodobenzovesamicol to the vesicular acetylcholine transporter.

4 do not express choline acetyltransferase or vesicular acetylcholine transporter.

5 ng protein toxin, to an antibody against the vesicular acetylcholine transporter.

6 ensities for [3H]vesamicol, which labels the vesicular acetylcholine transporter.

7 zovesamicol (IBVM), an in vivo marker of the vesicular acetylcholine transporter.

8 ning confocal microscopy, colocalized in PnO vesicular acetylcholine transporter, a presynaptic marke

9 of wild-type mice, is immunoreactive for the vesicular acetylcholine transporter, a recently identifi

10 Here, we used antibodies against the vesicular acetylcholine transporter and a new stereologi

11 ocytochemically with an antibody against the vesicular acetylcholine transporter and digitally photog

12 tylcholinesterase activities, and binding to vesicular acetylcholine transporter and Na(+)-dependent

13 Human alpha cells express the vesicular acetylcholine transporter and release acetylch

14 s encoding choline acetyltransferase and the vesicular acetylcholine transporter and up-regulated ace

15 ons lacked detectable immunoreactivities for vesicular acetylcholine transporter and vasoactive intes

16 was expressed in a minority of SP, VIP, NPY, vesicular acetylcholine transporter, and calcitonin gene

17 Calcitonin gene-related peptide, vesicular acetylcholine transporter, and tyrosine hydrox

18 ed to calculate [123I]-iodobenzovesamicol to vesicular acetylcholine transporter binding potential va

19 The septal cells stained for vesicular acetylcholine transporter, but not for ChAT, h

20 is transported into synaptic vesicles by the vesicular acetylcholine transporter encoded by unc-17.

21 ter binding potential value, proportional to vesicular acetylcholine transporter expression.

22 n capture of a vesicle membrane protein, the vesicular acetylcholine transporter, from single vesicle

23 s purpose also carries several copies of the vesicular acetylcholine transporter gene (VAChT), which

24 linergic gene locus, which contains both the vesicular acetylcholine transporter gene and the choline

25 now show that choline acetyltransferase and vesicular acetylcholine transporter homologs are prefere

26 The human homologue of the vesicular acetylcholine transporter (hVAChT) and the neu

27 ic terminals in the rat spinal cord by using vesicular acetylcholine transporter immunocytochemistry.

28 tions, a significantly greater proportion of vesicular acetylcholine transporter-immunoreactive (VACh

29 rase [ChAT] activity, the number of ChAT and vesicular acetylcholine transporter-immunoreactive neuro

30 amicol (FBT), which selectively binds to the vesicular acetylcholine transporter in the presynaptic c

31 A new class of vesicular acetylcholine transporter inhibitor that incor

32 In contrast, vesicular acetylcholine transporter-IR motor axon synaps

33 ur ongoing structure-activity studies of the vesicular acetylcholine transporter ligand 2-(4-phenylpi

34 mpound was more potent than the prototypical vesicular acetylcholine transporter ligand vesamicol.

35 l fragment of 1 will not lead to more potent vesicular acetylcholine transporter ligands.

36 as well as, reduced acetylcholinesterase and vesicular acetylcholine transporter mRNA.

37 s displayed moderately high affinity for the vesicular acetylcholine transporter, no compound was mor

38 ualized in brain sections stained for either vesicular acetylcholine transporter or choline acetyltra

39 ry motor neurons, labeled with antibodies to vesicular acetylcholine transporter or substance-P, were

40 ized on the same synaptic vesicles as either vesicular acetylcholine transporter or vesicular monoami

41 n addition, dual localization of M2R and the vesicular acetylcholine transporter protein (VAChT), a m

42 ections and does not require the function of vesicular acetylcholine transporter protein.

43 y and negatively charged residues of the rat vesicular acetylcholine transporter (rVAChT) were studie

44 Immunohistochemistry for the vesicular acetylcholine transporter showed that choliner

45 antibodies to choline acetyltransferase and vesicular acetylcholine transporter to label cholinergic

46 dobenzovesamicol, a SPECT radiotracer of the vesicular acetylcholine transporter, to evaluate in vivo

47 ampal sections were dually immunolabeled for vesicular acetylcholine transporter (VAChT) and ERalpha

48 ract-tracing and immunocytochemistry for the vesicular acetylcholine transporter (VAChT) and for tyro

49 col derivative that binds selectively to the vesicular acetylcholine transporter (VAChT) and has been

50 ampal sections were dually immunolabeled for vesicular acetylcholine transporter (VAChT) and MOR-1 an

51 reveals that CHT-positive vesicles carry the vesicular acetylcholine transporter (VAChT) and synaptic

52 including choline acetyltransferase (ChAT), vesicular acetylcholine transporter (VAChT) and the high

53 Validation of the vesicular acetylcholine transporter (VAChT) and the neur

54 col is a SPECT radioligand selective for the vesicular acetylcholine transporter (VAChT) and used to

55 Sequence-related vesicular acetylcholine transporter (VAChT) and vesicula

56 -12) cells stably transfected with the human vesicular acetylcholine transporter (VAChT) cDNA are des

57 The closely related vesicular acetylcholine transporter (VAChT) contains a s

58 ng with choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) immunohistoc

59 ed for the visualization of somatostatin and vesicular acetylcholine transporter (VAChT) immunoreacti

60 The unc-17 gene encodes the vesicular acetylcholine transporter (VAChT) in Caenorhab

61 the NK1 receptor and either 1) SP or 2) the vesicular acetylcholine transporter (VAchT) in rat NAc.

62 cutive function by genetically targeting the vesicular acetylcholine transporter (VAChT) in the mouse

63 roscopic dual immunolabeling of M2Rs and the vesicular acetylcholine transporter (VAchT) in the MPT o

64 cycle had an effect on the expression of the vesicular acetylcholine transporter (VAChT) in the SCN,

65 PPG(+) neurons do not express vesicular acetylcholine transporter (vAChT) in the VLM (

66 Vesicular acetylcholine transporter (VAChT) is inhibited

67 identifies dopaminergic neurons, whereas the vesicular acetylcholine transporter (VAchT) is present o

68 The vesicular acetylcholine transporter (VAChT) is responsib

69 In PC12 cells, the vesicular acetylcholine transporter (VAChT) localizes pr

70 The vesicular acetylcholine transporter (VAChT) mediates ACh

71 e cyclase-activating peptide (PACAP) and the vesicular acetylcholine transporter (VAChT) revealed tha

72 study indicated that there was an absence of vesicular acetylcholine transporter (VAChT) staining in

73 tudies with an antiserum that recognizes the vesicular acetylcholine transporter (VAChT) suggest, how

74 of antipeptide antiserum raised against the vesicular acetylcholine transporter (VAchT) that is resp

75 obutyric acid (GABA) transporter (VGAT), and vesicular acetylcholine transporter (VAChT) to determine

76 ructures by cholinergic axons expressing the vesicular acetylcholine transporter (VAChT) was also stu

77 A putative vesicular acetylcholine transporter (VAChT) was overexpr

78 The vesicular acetylcholine transporter (VAChT) was used as

79 for choline acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) was used to

80 ell line, A123.7, expressing recombinant rat vesicular acetylcholine transporter (VAChT) with radiola

81 unds having high potency and selectivity for vesicular acetylcholine transporter (VAChT), a heteroaro

82 (SP), vasoactive intestinal peptide (VIP) or vesicular acetylcholine transporter (VAchT), and their n

83 T2 along with three cholinergic markers: the vesicular acetylcholine transporter (VAChT), the high-af

84 fy selective high-affinity inhibitors of the vesicular acetylcholine transporter (VAChT), we have int

85 sion of choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are c

86 activity was localized in significantly more vesicular acetylcholine transporter (VAChT)-IR varicosit

87 loaded into synaptic vesicles by a specific vesicular acetylcholine transporter (VAChT).

88 12 putative transmembrane domains (TMDs) of vesicular acetylcholine transporter (VAChT).

89 the cytoplasm into synaptic vesicles by the vesicular acetylcholine transporter (VAChT).

90 the acetylcholine (ACh) binding site in the vesicular acetylcholine transporter (VAChT).

91 acetylcholine into synaptic vesicles by the vesicular acetylcholine transporter (VAChT).

92 d and evaluated as potential ligands for the vesicular acetylcholine transporter (VAChT).

93 line acetyltransferase (ChAT) and a putative vesicular acetylcholine transporter (VAChT).

94 ChAT), choline transporter 1 (CHT1, SLC5A7), vesicular acetylcholine transporter (VAChT, SLC18A3), an

95 398 in a three-dimensional homology model of vesicular acetylcholine transporter (VAChT, TC 2.A.1.2.1

96 histochemical markers for cholinergic cells (vesicular acetylcholine transporter [VAChT]), tyrosine h

97 histochemical markers for cholinergic cells (vesicular acetylcholine transporter [VAChT]), tyrosine h

98 ic synapses (75% +/- 14% colocalize with the vesicular acetylcholine transporter; VAChT).

99 bodies to glutamic acid decarboxylase (GAD), vesicular acetylcholine transporter (VAT), or the peptid

100 And, VACHT, the vesicular acetylcholine transporter, was highly correlat